Free Trial
OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

Mosaic ImmunoEngineering logo
$0.49 +0.13 (+37.08%)
As of 06/27/2025 03:05 PM Eastern

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Key Stats

Today's Range
$0.49
$0.54
50-Day Range
$0.27
$0.78
52-Week Range
$0.21
$1.13
Volume
200 shs
Average Volume
265 shs
Market Capitalization
$3.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

CPMV Stock News Headlines

Mosaic ImmunoEngineering, Inc. (CPMV) - Yahoo Finance
Mosaic ImmunoEngineering, Inc. (CPMV)
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
Mosaic Co.
See More Headlines

CPMV Stock Analysis - Frequently Asked Questions

Mosaic ImmunoEngineering's stock was trading at $0.7012 at the beginning of 2025. Since then, CPMV shares have decreased by 29.6% and is now trading at $0.4935.
View the best growth stocks for 2025 here
.

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) released its earnings results on Tuesday, May, 20th. The company reported ($0.03) earnings per share for the quarter.

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mosaic ImmunoEngineering investors own include BioNxt Solutions (BNXTF), Defense Metals (DFMTF), C3.ai (AI), Applied Genetic Technologies (AGTC), Agile Therapeutics (AGRX), AgriFORCE Growing Systems (AGRI) and

Company Calendar

Last Earnings
5/20/2025
Today
6/30/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CPMV
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$920 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
-0.53

Miscellaneous

Free Float
1,377,000
Market Cap
$3.57 million
Optionable
Not Optionable
Beta
-0.13
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:CPMV) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners